Physical Therapy Trial for Pelvic Pain
- Conditions
- Chronic ProstatitisChronic Pelvic Pain SyndromeInterstitial CystitisPainful Bladder Syndrome
- Interventions
- Other: Global Therapeutic Massage (GTM)Other: Myofascial physical therapy (MPT)
- Registration Number
- NCT00434343
- Brief Summary
The purpose of this study is to determine if a randomized trial of physical therapy for pelvic pain is feasible.
- Detailed Description
This is a pilot study wherein eligible participants will be randomly assigned to receive either myofascial tissue manipulation or global therapeutic massage. Those receiving myofascial tissue manipulation will have targeted internal and external connective tissue manipulation focusing on the muscles and connective tissues of the pelvic floor, hip girdle, and abdomen. Those receiving global therapeutic massage will have non-specific somatic treatment with full-body Western massage.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 47
- female and male patients who have failed to respond to previous therapies for interstitial cystitis/painful bladder syndrome
- male patients who have failed to respond to previous therapies for chronic prostatitis/chronic pelvic pain syndrome
- neurologic disorder affecting bladder
- bladder cancer, prostate cancer, or urethral cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Global Therapeutic Massage (GTM) Global Therapeutic Massage (GTM) Weekly massages consisting of full body Western massage for 1hour. Myofascial physical therapy (MPT) Myofascial physical therapy (MPT) Connective tissue manipulation to all body wall tissues of the abdominal wall, back, buttocks and thighs that clinically were found to contain connective tissue abnormalities and/or myofascial trigger point release to painful myofascial trigger points
- Primary Outcome Measures
Name Time Method Number consenting to join study out of eligible patients approached 6 months This study will recruit both female and male patients who have failed to respond to previous therapies for either Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) or male patients who have failed to respond to previous therapies for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS).
Number of times therapists adhered to prescribed therapeutic protocol 12 weeks For each therapy session therapy records are reviewed to determine whether the therapist followed the therapeutic protocol. Each therapy session is scored as adherent or non-adherent and the number of adherent sessions are recorded per participant
- Secondary Outcome Measures
Name Time Method Global response assessment (GRA) Global response assessment 12 weeks The global response assessment consists of the following question: "As compared to when you started the study, how would you rate your overall symptoms now?" 1. markedly worse, 2. moderately worse, 3. slightly worse, 4. the same, 5. slightly improved, 6. moderately improved, 7. markedly improved
Tolerability of treatment measured by number of treatment sessions participants completed 12 weeks Treatment session completion was tracked and used to measure tolerability of treatment.
Number of adverse events reported by the participants 12 weeks Number of adverse events reported by the participants
Trial Locations
- Locations (5)
Stanford University Medical Center
🇺🇸Stanford, California, United States
Northwestern University Feinberg School of Medicine
🇺🇸Chicago, Illinois, United States
Loyola University Medical Center
🇺🇸Maywood, Illinois, United States
William Beaumont Hospital
🇺🇸Royal Oak, Michigan, United States
Cleveland Clinic Foundation
🇺🇸Cleveland, Ohio, United States